393 related articles for article (PubMed ID: 11454808)
1. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
Mitchell SA; Grove J; Spurkland A; Boberg KM; Fleming KA; Day CP; Schrumpf E; Chapman RW;
Gut; 2001 Aug; 49(2):288-94. PubMed ID: 11454808
[TBL] [Abstract][Full Text] [Related]
2. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis.
Bernal W; Moloney M; Underhill J; Donaldson PT
J Hepatol; 1999 Feb; 30(2):237-41. PubMed ID: 10068102
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance.
Donaldson PT; Norris S; Constantini PK; Bernal W; Harrison P; Williams R
J Hepatol; 2000 Jun; 32(6):882-6. PubMed ID: 10898307
[TBL] [Abstract][Full Text] [Related]
4. Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population.
Neri TM; Cavestro GM; Seghini P; Zanelli PF; Zanetti A; Savi M; Podda M; Zuin M; Colombo M; Floreani A; Rosina F; Bianchi Porro G; Strazzabosco M; Okolicsanyi L
Dig Liver Dis; 2003 Aug; 35(8):571-6. PubMed ID: 14567462
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in tumour necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: associations with HLA-DR and -DQ alleles and subclinical markers.
Hirv K; Seyfarth M; Uibo R; Kull K; Salupere R; Latza U; Rink L
Scand J Gastroenterol; 1999 Oct; 34(10):1025-32. PubMed ID: 10563674
[TBL] [Abstract][Full Text] [Related]
6. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype.
McManus R; Wilson AG; Mansfield J; Weir DG; Duff GW; Kelleher D
Eur J Immunol; 1996 Sep; 26(9):2113-8. PubMed ID: 8814255
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?
Louis E; Peeters M; Franchimont D; Seidel L; Fontaine F; Demolin G; Croes F; Dupont P; Davin L; Omri S; Rutgeerts P; Belaiche J
Clin Exp Immunol; 2000 Jan; 119(1):64-8. PubMed ID: 10606965
[TBL] [Abstract][Full Text] [Related]
9. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter].
Yang J; Li CR; Li YB; Li RX; Sun LB; Huang HJ; Wang GB
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene.
Ho SY; Wang YJ; Chen HL; Chen CH; Chang CJ; Wang PJ; Chen HH; Guo HR
Cancer Causes Control; 2004 Sep; 15(7):657-63. PubMed ID: 15280623
[TBL] [Abstract][Full Text] [Related]
11. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study.
Mira JP; Cariou A; Grall F; Delclaux C; Losser MR; Heshmati F; Cheval C; Monchi M; Teboul JL; Riché F; Leleu G; Arbibe L; Mignon A; Delpech M; Dhainaut JF
JAMA; 1999 Aug; 282(6):561-8. PubMed ID: 10450718
[TBL] [Abstract][Full Text] [Related]
12. Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C.
Hov JR; Lleo A; Selmi C; Woldseth B; Fabris L; Strazzabosco M; Karlsen TH; Invernizzi P
J Hepatol; 2010 May; 52(5):712-7. PubMed ID: 20347497
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
Wiencke K; Spurkland A; Schrumpf E; Boberg KM
Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
[TBL] [Abstract][Full Text] [Related]
14. Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients.
Wiencke K; Louka AS; Spurkland A; Vatn M; Schrumpf E; Boberg KM;
J Hepatol; 2004 Aug; 41(2):209-14. PubMed ID: 15288468
[TBL] [Abstract][Full Text] [Related]
15. Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis.
Cookson S; Constantini PK; Clare M; Underhill JA; Bernal W; Czaja AJ; Donaldson PT
Hepatology; 1999 Oct; 30(4):851-6. PubMed ID: 10498633
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis.
Moloney MM; Thomson LJ; Strettell MJ; Williams R; Donaldson PT
Hepatology; 1998 Sep; 28(3):660-2. PubMed ID: 9731555
[TBL] [Abstract][Full Text] [Related]
18. Comparative genetic association of human leukocyte antigen class II and tumor necrosis factor-alpha with dermatitis herpetiformis.
Wilson AG; Clay FE; Crane AM; Cork MJ; Duff GW
J Invest Dermatol; 1995 May; 104(5):856-8. PubMed ID: 7738367
[TBL] [Abstract][Full Text] [Related]
19. Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.
Naess S; Björnsson E; Anmarkrud JA; Al Mamari S; Juran BD; Lazaridis KN; Chapman R; Bergquist A; Melum E; Marsh SG; Schrumpf E; Lie BA; Boberg KM; Karlsen TH; Hov JR
Liver Int; 2014 Nov; 34(10):1488-95. PubMed ID: 24517468
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease.
Bathgate AJ; Pravica V; Perrey C; Hayes PC; Hutchinson IV
Eur J Gastroenterol Hepatol; 2000 Dec; 12(12):1329-33. PubMed ID: 11192323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
